Women face many challenges when accessing health care during pregnancy. This can include financial, organizational, and cultural barriers that they may face from time to time.
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...